Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST and CA19-9/γ-GGT for jaundiced PDAC patients)
作者： Kuirong Jiang , Yi Miao , Zipeng Lu , Pengfei Wu , Baobao Cai
DOI: 10.1016/J.PAN.2021.05.300
关键词:
摘要: Abstract Background Carbohydrate antigen 19–9 (CA19-9) has been reported as the most significant survival predictor of patients with pancreatic ductal adenocarcinoma (PDAC) …
sci-hub.st 参考文章(43)
S Falkenreck, F Safi, H G Beger, W Schlosser, Prognostic value of CA 19-9 serum course in pancreatic cancer. Hepato-gastroenterology. ,vol. 45, pp. 253- 259 ,(1998)
Margaret A. Tempero, Parviz M. Pour, Zenon Steplewski, Eiji Uchida, David A. Burnett, Hideaki Takasaki, Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Research. ,vol. 47, pp. 5501- 5503 ,(1987)
Yoshihiro Shirai, Hiroaki Shiba, Taro Sakamoto, Takashi Horiuchi, Koichiro Haruki, Yuki Fujiwara, Yasuro Futagawa, Toya Ohashi, Katsuhiko Yanaga, Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection Surgery. ,vol. 158, pp. 360- 365 ,(2015) , 10.1016/J.SURG.2015.03.043
Hiroshi Imaoka, Nobumasa Mizuno, Kazuo Hara, Susumu Hijioka, Masahiro Tajika, Tsutomu Tanaka, Makoto Ishihara, Tatsuji Yogi, Hideharu Tsutsumi, Toshihisa Fujiyoshi, Takamitsu Sato, Yasuhiro Shimizu, Yasumasa Niwa, Kenji Yamao, Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study. Pancreas. ,vol. 45, pp. 211- 217 ,(2016) , 10.1097/MPA.0000000000000446
Torben F. Ørntoft, Harald Meyer, Hans Ole Hein, Else Marie Vestergaard, Niels Grunnet, Jan Jørgensen, Hans Wolf, Reference Values and Biological Variation for Tumor Marker CA 19-9 in Serum for Different Lewis and Secretor Genotypes and Evaluation of Secretor and Lewis Genotyping in a Caucasian Population Clinical Chemistry. ,vol. 45, pp. 54- 61 ,(1999) , 10.1093/CLINCHEM/45.1.54
Sherif R. Z. Abdel-Misih, Ioannis Hatzaras, Carl Schmidt, Tanios-Bekaii Saab, Dori Klemanski, Peter Muscarella, W. Scott Melvin, E. Christopher Ellison, Mark Bloomston, Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease. Annals of Surgical Oncology. ,vol. 18, pp. 1116- 1121 ,(2011) , 10.1245/S10434-010-1397-1
JACQUES PENDU, SÉVERINE MARIONNEAU, ANNE CAILLEAU-THOMAS, JÉZABEL ROCHER, BÉATRICE MOULLAC-VAIDYE, MONIQUE CLÉMENT, ABH and Lewis histo‐blood group antigens in cancer Apmis. ,vol. 109, pp. 9- 31 ,(2001) , 10.1111/J.1600-0463.2001.TB00011.X
Joshua G. Barton, John P. Bois, Michael G. Sarr, Christina M. Wood, Rui Qin, Kristine M. Thomsen, Michael L. Kendrick, Michael B. Farnell, Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma. Journal of Gastrointestinal Surgery. ,vol. 13, pp. 2050- 2058 ,(2009) , 10.1007/S11605-009-0849-Z
Young Choon Kim, Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Jun Ho Shin, Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma? Journal of Gastroenterology and Hepatology. ,vol. 24, pp. 1869- 1875 ,(2009) , 10.1111/J.1440-1746.2009.05935.X
Giuliano Barugola, Stefano Partelli, Stefano Marcucci, Nora Sartori, Paola Capelli, Claudio Bassi, Paolo Pederzoli, Massimo Falconi, Resectable Pancreatic Cancer: Who Really Benefits From Resection? Annals of Surgical Oncology. ,vol. 16, pp. 3316- 3322 ,(2009) , 10.1245/S10434-009-0670-7